Catch up on our latest webinars

Out-Licensing Lessons: How to Put Your Best Foot Forward

As a biotech or small biopharma company, how do you ensure you’re on the radar of potential partners to help you smooth your asset’s path to market? To be taken seriously, you need clear evidence of your asset’s efficacy and market potential, as well as a realistic view of the types of deals you can strike.

Watch Now

In-Licensing Lessons: Benchmarking Best Practice

For Big Pharma companies, biotechs present a world of potential opportunities to boost pipelines with reduced risk. However, it’s a very large ecosystem, which makes it difficult to identify, screen and select the assets that fit your strategy. Biotechs have big dreams and finding mutually acceptable common ground is key to a successful partnership.

Watch Now

Licence Drivers: Trends in Pharma Dealmaking

Explore where blockbuster drugs, earning over $1bn annually, come from and discover strategies for finding the next big pharma success

Watch Now

Catch up with our insights

Struggling to find the right partners or validate asset potential with confidence?

Business development teams face mounting pressure to identify high-value opportunities, justify investment decisions, and close deals in a competitive, fast-moving landscape. Limited internal bandwidth, fragmented data, and evolving market dynamics make it harder to build compelling value narratives and negotiate effectively.


Our consulting & analytics team offer strategic guidance, commercial valuation expertise, and deal benchmarking to accelerate smarter partnerships and portfolio growth.

How we help

Asset Screening

Check your assumptions, conduct deep due diligence, and assess the value of a potential target or your own portfolio with objectivity. Whether you are looking to expand your product pipelines or enter new markets, find out how our asset screening tools can inform your strategic decision-making.

Company Profiling

Identify, profile, and monitor companies aligned with your growth strategy. Track financials, pipeline updates, M&A activity, and other pertinent details. Validate potential investments with confidence and strategise your portfolio for maximum returns.

Deal Benchmarking

Establish product acquisition opportunities, negotiate, and structure deals with potential partners based on historical comparable deals. Tailor custom benchmarks and scrutinise internal valuations to benchmark performance and measure success

Ready to see how Evaluate can help you make smarter decisions?

Get in touch with our team to explore the right solutions for your business.